{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:39:00Z","timestamp":1792251540356,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T00:00:00Z","timestamp":1449792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (AU)","doi-asserted-by":"publisher","award":["1001456"],"award-info":[{"award-number":["1001456"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00198-015-3432-3","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T12:02:37Z","timestamp":1449835357000},"page":"1737-1745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV"],"prefix":"10.1007","volume":"27","author":[{"name":"on behalf of the STEAL Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.","family":"Klassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Kimlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. K.","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R.","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"key":"3432_CR1","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"T Brown","year":"2006","unstructured":"Brown T, Qaqish R (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20:2165\u20132174","journal-title":"AIDS"},{"key":"3432_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QCO.0b013e328334fe9a","volume":"23","author":"PW Mallon","year":"2010","unstructured":"Mallon PW (2010) HIV and bone mineral density. Curr Opin Infect Dis 23:1\u20138","journal-title":"Curr Opin Infect Dis"},{"key":"3432_CR3","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","volume":"93","author":"VA Triant","year":"2008","unstructured":"Triant VA, Brown TT, Lee H, Grinspoon SK (2008) Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 93:3499\u20133504","journal-title":"J Clin Endocrinol Metab"},{"key":"3432_CR4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/cid\/ciq242","volume":"52","author":"B Young","year":"2011","unstructured":"Young B, Dao CN, Buchacz K, Baker R, Brooks JT (2011) Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000\u20132006. Clin Infect Dis 52:1061\u20131068","journal-title":"Clin Infect Dis"},{"key":"3432_CR5","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1097\/QAD.0b013e32833f6294","volume":"24","author":"MT Yin","year":"2010","unstructured":"Yin MT, Shi Q, Hoover DR et al (2010) Fracture incidence in HIV-infected women: results from the Women\u2019s Interagency HIV Study. AIDS 24:2679\u20132686","journal-title":"AIDS"},{"key":"3432_CR6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e32835192ae","volume":"26","author":"R Bedimo","year":"2012","unstructured":"Bedimo R, Maalouf NM, Zhang S, Drechsler H, Tebas P (2012) Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS 26:825\u2013831","journal-title":"AIDS"},{"key":"3432_CR7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044845","volume":"7","author":"K Klassen","year":"2012","unstructured":"Klassen K, Martineau AR, Wilkinson RJ, Cooke G, Courtney AP, Hickson M (2012) The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity. PLoS One 7, e44845","journal-title":"PLoS One"},{"key":"3432_CR8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/QAD.0b013e328337b161","volume":"24","author":"NJ Mueller","year":"2010","unstructured":"Mueller NJ, Fux CA, Ledergerber B et al (2010) High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 24:1127\u20131134","journal-title":"AIDS"},{"key":"3432_CR9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2009.142","volume":"5","author":"H Izzedine","year":"2009","unstructured":"Izzedine H, Harris M, Perazella MA (2009) The nephrotoxic effects of HAART. Nat Rev Nephrol 5:563\u2013573","journal-title":"Nat Rev Nephrol"},{"key":"3432_CR10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1089\/aid.2011.0325","volume":"28","author":"CK Kwan","year":"2012","unstructured":"Kwan CK, Eckhardt B, Baghdadi J, Aberg JA (2012) Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York. AIDS Res Hum Retroviruses 28:1025\u20131032","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3432_CR11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1310\/hct1303-162","volume":"13","author":"U Bang","year":"2012","unstructured":"Bang U, Kolte L, Hitz M, Nielsen SD, Schierbeck LL, Andersen O, Haugaard SB, Mathiesen L, Benfield T, Jensen J-EB (2012) Correlation of increases in 1,25-dihydroxyvitamin D during vitamin D therapy with activation of CD4+ T lymphocytes in HIV-1-infected males. HIV Clin Trials 13:162\u2013170","journal-title":"HIV Clin Trials"},{"key":"3432_CR12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/cid\/cir968","volume":"54","author":"PL Havens","year":"2012","unstructured":"Havens PL, Stephensen CB, Hazra R et al (2012) Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin Infect Dis 54:1013\u20131025","journal-title":"Clin Infect Dis"},{"key":"3432_CR13","first-page":"A42","volume":"15","author":"P Labarga","year":"2010","unstructured":"Labarga P, Barreiro P, Martin-Carbonero L et al (2010) Prevalence of hyperparathyroidism in HIV-infected patients under antiretrovirals. Antivir Ther 15:A42\u2013A42","journal-title":"Antivir Ther"},{"key":"3432_CR14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/aid.2009.0308","volume":"26","author":"KE Childs","year":"2010","unstructured":"Childs KE, Fishman SL, Constable C, Gutierrez JA, Wyatt CM, Dieterich DT, Mullen MP, Branch AD (2010) Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses 26:855\u2013859","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3432_CR15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/QAI.0b013e3181caebaa","volume":"54","author":"MM Rosenvinge","year":"2010","unstructured":"Rosenvinge MM, Gedela K, Copas AJ, Wilkinson A, Sheehy CA, Bano G, Hay PE, Pakianathan MR, Sadiq ST (2010) Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. J Acquir Immune Defic Syndr 54:496\u2013499","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3432_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0052","volume":"28","author":"M Masi\u00e1","year":"2012","unstructured":"Masi\u00e1 M, Padilla S, Robledano C, L\u00f3pez N, Ramos JM, Guti\u00e9rrez F (2012) Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir. AIDS Res Hum Retroviruses 28:242\u2013246","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3432_CR17","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","volume":"56","author":"M Rix","year":"1999","unstructured":"Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084\u20131093","journal-title":"Kidney Int"},{"key":"3432_CR18","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/644769","volume":"49","author":"A Martin","year":"2009","unstructured":"Martin A, Bloch M, Amin J, Baker D, Cooper DA, Emery S, Carr A (2009) Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: a randomized, 96-week trial. Clin Infect Dis 49:1591\u20131601","journal-title":"Clin Infect Dis"},{"key":"3432_CR19","unstructured":"World Health Organization (2004) WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level"},{"key":"3432_CR20","unstructured":"World Health Organization (2004) WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level. Geneva, Switzerland, p 17 pages"},{"key":"3432_CR21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1755-5922.2010.00141.x","volume":"29","author":"DT Ertugrul","year":"2011","unstructured":"Ertugrul DT, Yavuz B, Cil H, Ata N, Akin KO, Kucukazman M, Yalcin AA, Dal K, Yavuz BB, Tutal E (2011) STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D. Cardiovasc Ther 29:146\u2013152","journal-title":"Cardiovasc Ther"},{"key":"3432_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53\u201358","journal-title":"J Clin Endocrinol Metab"},{"key":"3432_CR23","doi-asserted-by":"crossref","first-page":"686","DOI":"10.5694\/mja11.10301","volume":"196","author":"CA Nowson","year":"2012","unstructured":"Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, Seibel MJ, Mason RS (2012) Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 196:686\u2013687","journal-title":"Med J Aust"},{"key":"3432_CR24","unstructured":"WHO Consultation on Obesity (1999) Obesity: preventing and managing the global epidemic: report of a WHO consultation. In World Health Organization (ed) WHO technical report series: 894Geneva, Switzerland"},{"key":"3432_CR25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/php.12390","volume":"91","author":"KM Klassen","year":"2015","unstructured":"Klassen KM, Fairley CK, Kimlin MG, Kelly M, Read TR, Broom J, Russell DB, Ebeling PR (2015) Ultraviolet index and location are important determinants of vitamin D status in people with human immunodeficiency virus (HIV). Photochem Photobiol 91:431\u2013437","journal-title":"Photochem Photobiol"},{"key":"3432_CR26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/QAD.0b013e328347f6f7","volume":"25","author":"JP Viard","year":"2011","unstructured":"Viard JP, Souberbielle JC, Kirk O et al (2011) Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 25:1305\u20131315","journal-title":"AIDS"},{"key":"3432_CR27","volume":"7","author":"Haskelberg H, Hoy JF, Amin J, Ebeling PR, Emery S, Carr A, Group SS","year":"2012","unstructured":"Haskelberg H, Hoy JF, Amin J, Ebeling PR, Emery S, Carr A, Group SS (2012) Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. PLoS One 7, e38377","journal-title":"PLoS One"},{"key":"3432_CR28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1359\/jbmr.081242","volume":"24","author":"HA Bischoff-Ferrari","year":"2009","unstructured":"Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, Orav JE, Li RF, Spiegelman D, Dietrich T, Willett WC (2009) Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among US adults. J Bone Miner Res 24:935\u2013942","journal-title":"J Bone Miner Res"},{"key":"3432_CR29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","volume":"367","author":"HA Bischoff-Ferrari","year":"2012","unstructured":"Bischoff-Ferrari HA, Willett WC, Orav EJ et al (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367:40\u201349","journal-title":"N Engl J Med"},{"key":"3432_CR30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/QAI.0b013e3181bf6471","volume":"53","author":"MT Yin","year":"2010","unstructured":"Yin MT, Lu D, Cremers S, Tien PC, Cohen MH, Shi Q, Shane E, Golub ET, Anastos K (2010) Short-term bone loss in HIV-infected premenopausal women. J Acquir Immune Defic Syndr 53:202\u2013208","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3432_CR31","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-005-1845-0","volume":"16","author":"M Yin","year":"2005","unstructured":"Yin M, Dobkin J, Brudney K, Becker C, Zadel JL, Manandhar M, Addesso V, Shane E (2005) Bone mass and mineral metabolism in HIV+ postmenopausal women. Osteoporos Int 16:1345\u20131352","journal-title":"Osteoporos Int"},{"key":"3432_CR32","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1128\/AAC.01096-13","volume":"57","author":"PL Havens","year":"2013","unstructured":"Havens PL, Kiser JJ, Stephensen CB et al (2013) Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother 57:5619\u20135628","journal-title":"Antimicrob Agents Chemother"},{"key":"3432_CR33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0b013e328332d32d","volume":"23","author":"V Soriano","year":"2009","unstructured":"Soriano V, Labarga P, Barreiro P et al (2009) Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS 23:689\u2013696","journal-title":"AIDS"},{"key":"3432_CR34","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1086\/644785","volume":"200","author":"A Calmy","year":"2009","unstructured":"Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A (2009) Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. J Infect Dis 200:1746\u20131754","journal-title":"J Infect Dis"},{"key":"3432_CR35","unstructured":"Gilead Sciences I (2015) Gilead Submits New Drug Application to U.S. Food and Drug Administration for Fixed-Dose Combination of Emtricitabine\/Tenofovir Alafenamide for HIV Treatment http:\/\/www.gilead.com\/news\/press-releases\/2015\/4\/gilead-submits-new-drug-application-to-us-food-and-drug-administration-for-fixeddose-combination-of-emtricitabinetenofovir-alafenamide-for-hiv-treatment Accessed 17 June 2015"},{"key":"3432_CR36","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/jc.2007-1660","volume":"92","author":"MJ Bolland","year":"2007","unstructured":"Bolland MJ, Grey AB, Gamble GD, Reid IR (2007) CLINICAL review #: low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab 92:4522\u20134528","journal-title":"J Clin Endocrinol Metab"},{"key":"3432_CR37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00198-005-1857-9","volume":"16","author":"J Laitinen","year":"2005","unstructured":"Laitinen J, Kiukaanniemi K, Heikkinen J, Koiranen M, Nieminen P, Sovio U, Kein\u00e4nen-Kiukaanniemi S, J\u00e4rvelin MR (2005) Body size from birth to adulthood and bone mineral content and density at 31 years of age: results from the northern Finland 1966 birth cohort study. Osteoporos Int 16:1417\u20131424","journal-title":"Osteoporos Int"},{"key":"3432_CR38","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1742-1241.2009.02301.x","volume":"64","author":"EA Greco","year":"2010","unstructured":"Greco EA, Fornari R, Rossi F et al (2010) Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int J Clin Pract 64:817\u2013820","journal-title":"Int J Clin Pract"},{"key":"3432_CR39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2796.2002.01050.x","volume":"252","author":"KJ Stewart","year":"2002","unstructured":"Stewart KJ, Deregis JR, Turner KL, Bacher AC, Sung J, Hees PS, Tayback M, Ouyang P (2002) Fitness, fatness and activity as predictors of bone mineral density in older persons. J Intern Med 252:381\u2013388","journal-title":"J Intern Med"},{"key":"3432_CR40","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1210\/jc.2006-0572","volume":"92","author":"LJ Zhao","year":"2007","unstructured":"Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW (2007) Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 92:1640\u20131646","journal-title":"J Clin Endocrinol Metab"},{"key":"3432_CR41","doi-asserted-by":"crossref","first-page":"500S","DOI":"10.1093\/ajcn\/88.2.500S","volume":"88","author":"A Prentice","year":"2008","unstructured":"Prentice A, Goldberg GR, Schoenmakers I (2008) Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 88:500S\u2013506S","journal-title":"Am J Clin Nutr"},{"key":"3432_CR42","doi-asserted-by":"crossref","DOI":"10.5888\/pcd10.130183","volume":"10","author":"E V\u00e1squez","year":"2013","unstructured":"V\u00e1squez E, Shaw BA, Gensburg L, Okorodudu D, Corsino L (2013) Racial and ethnic differences in physical activity and bone density: National Health and Nutrition Examination Survey, 2007\u20132008. Prev Chronic Dis 10, E216","journal-title":"Prev Chronic Dis"},{"key":"3432_CR43","doi-asserted-by":"crossref","unstructured":"Overton ET, Chan ES, Brown TT, Tebas P, McComsey GA, Melbourne KM, Napoli A, Hardin R, Ribaudo HJ, Yin MT (2014) High-dose vitamin D and calcium attenuates bone loss with ART initiation: results from ACTG A5280. CROI","DOI":"10.7326\/M14-1409"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3432-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3432-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3432-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T06:53:40Z","timestamp":1567407220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3432-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["3432"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3432-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]}}}